Search Results

Inquis Medical’s Aventus Thrombectomy System Studied to Treat Pulmonary Embolism

May 6, 2025—Inquis Medical recently announced that the AVENTUS trial evaluating the company’s investigational Aventus thrombectomy system met its primary endpoints, demonstrating both safety and efficacy in the treatment of acute intermediate-risk pulmonary embolism (PE).

Inquis’ Aventus Thrombectomy System Cleared to Treat PE

June 16, 2025—Inquis Medical announced that its Aventus mechanical thrombectomy system has received FDA 510(k) clearance for an expanded indication to treat pulmonary embolism (PE).

Inquis Medical Raises Financing for Commercialization of Aventus Thrombectomy System

January 14, 2026—Inquis Medical, Inc., a privately held medical device company focused on mechanical thrombectomy for venous thromboembolic disease, announced the closing of a $75 million Series C financing round.